Subscribe for the newsletter
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Directory
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Promentis Pharmaceuticals
Sort By
Newest First
Sign in
1 / 1
1 / 1
Clinical Trial
Promentis Pharmaceuticals Announces Successful Completion of Phase 1 Studies for SXC-2023 Targeting Novel Glutamatergic Mechanism
Promentis Pharmaceuticals
PR-M11-18-NI-084
Nov 23, 2018
